TREAT (Telemedicine for Reach, Education, Access, and Treatment)

TREAT (Telemedicine for Reach, Education, Access, and Treatment)

The purpose of this study is to evaluate the feasibility and clinical efficacy of an innovative care model that combines Telemedicine consultations, educator therapeutic management and diabetes education to empower patients to be in greater control of their own diabetes care for improvements in diabetes outcomes.

This study will assess whether a new care delivery model combining telemedicine videoconference diabetes consultations with diabetes self-management teaching is efficacious in reducing HbA1c in patients with type 2 diabetes in rural areas. The control group will consist of patients with type 2 diabetes receiving "usual care", i.e., who have not received a referral to the endocrinologist telemedicine team. Secondary outcomes include patient satisfaction, level of understanding of self-management skills, and hypoglycemia

Inclusion Criteria:

• Age 18 or older with type 2 diabetes
• Referral by a primary care provider.
• HbA1c equal or greater than 7.0%.

Exclusion Criteria:

• Type 1 diabetes
• Gestational Diabetes